Your browser doesn't support javascript.
loading
FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer.
Long, Yufei; Chong, Tuotuo; Lyu, Xiaoming; Chen, Lujia; Luo, Xiaomin; Faleti, Oluwasijibomi Damola; Deng, Simin; Wang, Fei; He, Mingliang; Qian, Zhipeng; Zhao, Hongli; Zhou, Wenyan; Guo, Xia; Chen, Ceshi; Li, Xin.
Afiliación
  • Long Y; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
  • Chong T; The Third School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
  • Lyu X; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
  • Chen L; The Third School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
  • Luo X; Department of laboratory medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Faleti OD; Breast Center, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Deng S; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
  • Wang F; The Third School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
  • He M; Department of laboratory medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Qian Z; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
  • Zhao H; Department of laboratory medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Zhou W; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
  • Guo X; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
  • Chen C; Guangzhou SaiCheng Bio Co. Ltd, Guangzhou, Guangdong, China.
  • Li X; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
J Exp Clin Cancer Res ; 41(1): 301, 2022 Oct 13.
Article en En | MEDLINE | ID: mdl-36229838
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Anexina A2 / Células Neoplásicas Circulantes Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Anexina A2 / Células Neoplásicas Circulantes Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido